I’m Eric. Scientist by training. Builder by instinct. Happiest when a good idea turns into something real.
Get inside my headCURRENTLYOxiProteomicsQIMA Life Sciences · North America
ALSO IN MY ORBITPixkanaka Ventures KEEP EXPLORINGA research paper. A new product. A conversation that becomes a collaboration.
Those might sound like different worlds. I’ve spent my career moving between them, from HPV research at Boston College to commercial leadership, innovation and entrepreneurship.
I like understanding the science, finding the story, and getting the right people excited about what comes next. Sometimes that means a partnership. Sometimes a brand. Sometimes rolling up my sleeves and building a tool.
There’s a story behind that01Scientific roots.
02Creative instinct.
03Human energy.
Different projects. Different questions.
The same urge to make things happen.
01 / MY CURRENT CHAPTER
At OxiProteomics, I lead business development and strategy for North America, connecting proteomics, biomarkers and longevity science with the teams that can use them.
Current conversations include Longevity SCORE, an OxiProteomics offering. My focus is the path from scientific capability to a clear, useful proposition.
Explore OxiProteomics02 / THE BUILDER SIDE
Does the government already fund work like this? GrantScope is Pixkanaka’s answer: a tool that helps life-science teams explore funding signals and comparable awards.
From a recurring question to something people can use. An example of why I like building, not just talking about building.
Meet GrantScope03 / AN ENTREPRENEURIAL CHAPTER
Augmented Bio grew from an interest in the space between healthcare, technology and lived experience.
A founder chapter that brought a different set of questions: what are we missing, who should we listen to, and how could technology help?
The founder conversationPixkanakaventures
Pixkanaka is where my work in life sciences meets my appetite for making things: a commercial direction, a sharper identity, a new product, a useful tool.
The name means “little by little” in Basque. It’s a good way to build something that lasts. One considered step, then the next.
Step into PixkanakaA few questions, ideas and experiments
from my LinkedIn feed.
Not a content strategy. A curious mind at work.
“I wondered if AI could make the point land in twenty seconds, so I let it try.”
A short AI-video experiment to bring the Longevity SCORE conversation to life. Because a serious subject can still have a sense of humor.
Watch the original post“The key is staying curious enough to connect dots others might miss.”
Tesla coils making music, new research, and the unexpected connections that keep me learning.
“The human element in networking has never been more critical than it is today.”
Genuine scientific curiosity, conversations across disciplines, and connections that go beyond a contact list.
“One thing is clear: tech adoption needs community validation, not good science alone.”
On the role of demonstrations, evidence, peer conversations and the people in the room when new technology reaches the lab.
“So how do we accelerate the shift from viewing women’s health as optional to treating it as essential infrastructure?”
Reflections from a French Tech Boston panel at Withings on access, technology and the way we frame women’s health.
“It’s RAG time in biotech and pharma!”
Exploring retrieval-augmented generation and how scientific sources can inform the AI tools we build.
Selected posts, not a live feed. Quoted passages are excerpts; card titles and introductions are editorial summaries. Each link opens the original post.
Reflections from the FACCNE 2025 Life Sciences Panorama.
Read the pieceNew ways of thinking about biotech, pharma and human-relevant models.
Read the pieceA perspective on the changing possibilities of mRNA therapeutics.
Read the piece2024The Ethical Application of Behavioral Economics in Business
2023The Glass Is Always Full: Innovating the Future of Drug Development
2023Three Years On: Reflecting on Moderna’s First Phase 1 COVID Vaccines & The Evolution of Our Industry
2017Impacting Earth & Beyond through Biotech Innovation. WOW. What a year!
2015There’s LIFE in Life Sciences!
2015Securing Opportunities in a Rapidly Shifting & Competitive World
20153D Printing Pharmaceuticals
Browse the articles on LinkedIn ↗Some ideas are easier to see.
Two pieces from the SCORE creative archive. Open either one to explore the full illustration.Layered paper, skin biology and a clear next question. A visual study for Longevity SCORE.
A portrait-format exploration of the same visual language.
Existing creative artwork for OxiProteomics / QIMA Life Sciences. These are illustrations, not microscopy, clinical evidence or measured results.
The scientific roots run deep: from HPV nuclear transport to human skin immunology. Four journal publications and one separately labeled conference contribution.
2024ALLERGY / COAUTHOR
SCIENCE ADVANCES / COAUTHOR
VIROLOGY / COAUTHOR
COLD SPRING HARBOR LABORATORIES / CONFERENCE CONTRIBUTION
Listed on LinkedIn. View profile for the original entry.
JOURNAL OF CELLULAR BIOCHEMISTRY / FIRST AUTHOR
Research. Commercial leadership. Strategic alliances. New ventures. The interesting part has always been what connects them.
Head of Business Development & Strategy,
North America
Part of QIMA Life Sciences. Connecting proteomics, biomarkers and longevity science with North American markets.
Founder
An entrepreneurial chapter at the intersection of healthcare, technology and human experience.
A conversation on health-tech entrepreneurship ↗Commercial & innovation leadership
Chief Commercial Officer and, subsequently, Chief Business Innovation Officer. Working to bring human ex vivo skin models into the drug-development conversation.
Listen to the Genoskin conversation ↗Senior Director, Strategic Alliances & Innovation
Consumer-sector portfolio development and business strategy.
Life Sciences commercial strategy
Developing growth strategies for the Life Sciences division.
COMMERCIAL FOUNDATIONS
Commercial roles at Cellectis, Sigma Aldrich, Becton Dickinson and Fisher Scientific.
BOSTON COLLEGE / 1996–2002
Research into human papillomavirus proteins and nuclear transport, with publications in the Journal of Cellular Biochemistry and Virology.
Explore the research ↓Good ideas travel.
People help them land.
A big part of my world is connecting French innovation with the US life-science community, through mentorship, shared questions and the kind of introductions that turn into real work.
Board Member & US Life Sciences Co-Chair
Founding Partner / FACCNE
Track Co-Chair
Biotech startup mentor, 2017–2018.
Funding, branding and commercialization.
Catalyst / volunteer.
Part of the innovation community since 2012.
A DIFFERENT PERSPECTIVE
“I have never worked with anyone that combines technical acumen with creativity and sales skills quite like Eric.”
Sahil NockExcerpt from a LinkedIn recommendation ↗
A scientific question. A new venture.
A creative itch. Something worth exploring.
Tell me about it.